FDA Inspection 1030818 — Fairfax Cryobank, Inc.
The FDA completed an inspection of Fairfax Cryobank, Inc. on Oct 25, 2017 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 25, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Francisco, CA (United States)